| NEKTAR THERAPEUTICS |
| USA |
| Gesundheit |
| US6402683063 / A419UB |
| ITH0 (Frankfurt) / NKTR (NASDAQ) |
| FRA:ITH0, ETR:ITH0, ITH0:GR, NASDAQ:NKTR |
| - |
| https://www.nektar.com/ |
|
Nektar Therapeutics, a biopharmaceutical company, ..
>Volltext.. |
| 1143.66 Mio. EUR |
| 1055.81 Mio. EUR |
| 53.97 Mio. EUR |
| -116.56 Mio. EUR |
| -104.1 Mio. EUR |
| -6.83 EUR |
| 144.05 Mio. EUR |
| 14.07 Mio. EUR |
| -163.59 Mio. EUR |
| 4.07 |
| -36.23% |
| 31.93% |
| - |
| - |
| - |
| NEKTAR THERAPEUTICS, NEKTAR THERAPEUTIC |
| 01.12.25 |
|